MICROBOT MEDICAL INC (MBOT) Stock Price & Overview

NASDAQ:MBOTUS59503A2042

Current stock price

2.44 USD
+0.01 (+0.41%)
Last:

The current stock price of MBOT is 2.44 USD. Today MBOT is up by 0.41%. In the past month the price decreased by -10.99%. In the past year, price decreased by -2.41%.

MBOT Key Statistics

52-Week Range1.6001 - 4.62
Current MBOT stock price positioned within its 52-week range.
1-Month Range2.23 - 2.785
Current MBOT stock price positioned within its 1-month range.
Market Cap
163.87M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.30
Dividend Yield
N/A

MBOT Stock Performance

Today
+0.41%
1 Week
+6.11%
1 Month
-10.99%
3 Months
+13.02%
Longer-term
6 Months -11.96%
1 Year -2.41%
2 Years +163.42%
3 Years +62.00%
5 Years -67.38%
10 Years N/A

MBOT Stock Chart

MICROBOT MEDICAL INC / MBOT Daily stock chart

MBOT Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to MBOT. When comparing the yearly performance of all stocks, MBOT turns out to be only a medium performer in the overall market: it outperformed 47.36% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

MBOT Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to MBOT. While MBOT has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MBOT Earnings

Next Earnings DateMay 12, 2026
Last Earnings DateMar 26, 2026
PeriodQ4 / 2025
EPS Reported-$0.04
Revenue Reported
EPS Surprise 34.64%
Revenue Surprise -100.00%

MBOT Forecast & Estimates

9 analysts have analysed MBOT and the average price target is 7.65 USD. This implies a price increase of 213.52% is expected in the next year compared to the current price of 2.44.

For the next year, analysts expect an EPS growth of -17.87% and a revenue growth 4200% for MBOT


Analysts
Analysts82.22
Price Target7.65 (213.52%)
EPS Next Y-17.87%
Revenue Next Year4200%

MBOT Groups

Sector & Classification

MBOT Financial Highlights

Over the last trailing twelve months MBOT reported a non-GAAP Earnings per Share(EPS) of -0.3. The EPS increased by 59.46% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-13.14M
Industry RankSector Rank
PM (TTM) N/A
ROA -16.12%
ROE -16.95%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%80%
Sales Q2Q%N/A
EPS 1Y (TTM)59.46%
Revenue 1Y (TTM)N/A

MBOT Ownership

Ownership
Inst Owners17.52%
Shares67.16M
Float67.16M
Ins Owners1.47%
Short Float %12%
Short Ratio3.59

About MBOT

Company Profile

MBOT logo image Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 21 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.

Company Info

IPO: 1992-03-25

MICROBOT MEDICAL INC

175 Derby St Bld 27

Hingham MASSACHUSETTS 02043 US

CEO: Harel Gadot

Employees: 21

MBOT Company Website

MBOT Investor Relations

Phone: 17818753605

MICROBOT MEDICAL INC / MBOT FAQ

What does MICROBOT MEDICAL INC do?

Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 21 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.


Can you provide the latest stock price for MICROBOT MEDICAL INC?

The current stock price of MBOT is 2.44 USD. The price increased by 0.41% in the last trading session.


What is the dividend status of MICROBOT MEDICAL INC?

MBOT does not pay a dividend.


What is the ChartMill technical and fundamental rating of MBOT stock?

MBOT has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Where is MICROBOT MEDICAL INC (MBOT) stock traded?

MBOT stock is listed on the Nasdaq exchange.


Is MICROBOT MEDICAL INC (MBOT) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MBOT.


What is the market capitalization of MBOT stock?

MICROBOT MEDICAL INC (MBOT) has a market capitalization of 163.87M USD. This makes MBOT a Micro Cap stock.